The CRL7FBXW8 Complex Controls the Mammary Stem Cell Compartment Through Regulation of NUMB Levels
Sabbioni, S.; Filippone, M. G.; Amadori, L.; Confalonieri, S.; Bonfanti, R.; Capoano, S.; Colaluca, I. N.; Freddi, S.; Bertalot, G.; Faga, G.; Zagarri, E.; Varasi, M.; Gunby, R. H.; Mercurio, C.; Pece, S.; Di Fiore, P. P.; Tosoni, D.
Show abstract
NUMB is a tumor suppressor gene that functions by inhibiting the action of the NOTCH proto-oncogene and enhancing the levels and activity of the tumor suppressor protein p53. In breast cancer (BC), NUMB loss-of-function (LOF), mediated by various molecular mechanisms, is a frequent and causal event. Herein, we establish that loss of NUMB protein, resulting from protein hyper-degradation, is the prevalent mechanism of NUMB LOF in BC. Through a RNAi-based screening, we identified the CRL7FBXW8 complex as the E3 ligase complex responsible for NUMB hyper-degradation in BC. Genetic and pharmacological inhibition of CRL7FBXW8 rescued the transformation-related phenotypes induced by NUMB LOF in BC cell lines and in patient-derived xenografts. These effects were directly dependent on the restoration of NUMB protein levels. Thus, enhanced CRL7FBXW8 activity, through its interference with the tumor suppressor activity of NUMB, is a causal alteration in BC, suggesting it as a potential therapeutic target for precision medicine.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- HIF-dependent expression of creatine kinase brain isoform (CKB) promotes breast cancer metastasis, whereas cyclocreatine therapy impairs invasion and improves the efficacy of conventional chemotherapies 95%
- Casein kinase 1D encodes a novel drug target in Hedgehog-GLI driven cancers and tumor-initiating cells resistant to SMO inhibition 95%
- The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma 94%
Similar papers in this journal
- Isoform-specific functions of Numb in breast cancer progression, metastasis and proteome remodeling. 95%
- A SNAI2-PEAK1 stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting a cytokine expression profile that converges on PI3K/Akt signaling 94%
- Polyploid cancer cells reveal signatures of chemotherapy resistance 94%
Similar papers in this journal
- Integrative analysis of patient-derived tumoroids and ex vivo organoid modeling of ARID1A loss in bladder cancer reveals therapeutic molecular targets 95%
- Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer 94%
- ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to γδ T cell immunotherapy 94%